Parkinson’s disease (PD) is a neurodegenerative brain disease that progressively leads to motor dysfunction and cognitive decline. It affects more than 10 million people worldwide.
Focused ultrasound has international and FDA approval to treat tremor-dominant PD and is being assessed to treat Parkinson’s dyskinesia, which is characterized by uncontrolled, involuntary movements of the face, arms, legs, or trunk. Focused ultrasound–induced blood-brain barrier opening and subsequent delivery of therapeutics may also have the potential to curb, or even reverse, the progression of the underlying disease.
As Parkinson's Awareness Month comes to a close, we are sharing important progress that has been made in the field, bringing hope to countless patients worldwide.
After first noticing symptoms in 2017, Rich Nagy underwent focused ultrasound therapy for Parkinson's disease in 2020. He has since been able to resume his hobbies, including playing the violin and boxing.
In the US, 20.7 million Medicare beneficiaries have access to focused ultrasound–based treatment of tremor-dominant Parkinson's disease. The procedure is also reimbursed in five other countries.
The field of focused ultrasound for Parkinson's disease is expanding rapidly as researchers widen the scope of possibilities, clinicians treat more patients, and sites launch clinical trials. Meet some of those leading the field.
The Eddie and Jo Allison Smith Foundation Fund for Focused Ultrasound Treatment of Neurodegenerative Disorders will support research for disorders such as Alzheimer’s disease, Parkinson’s, ALS, and Huntington’s.
Today, April 29, at 12:30pm Eastern, the Foundation will host a live Twitter chat discussing focused ultrasound for Parkinson's disease. Follow along at @FUSFoundation and participate using #ParkinsonsChat.
Foundation Chairman Neal F. Kassell, MD, recently sat down virtually with two leading clinicians to discuss focused ultrasound's role in treating – and perhaps reversing – the symptoms of Parkinson’s.
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
